Background: The use of acellular dermal matrices (ADMs) by plastic surgeons has become increasingly popular in immediate and delayed tissue expander/ implant based breast reconstruction. (1) However, it is unclear whether ADM use increases postoperative complication rates. (2-5) We conducted a controlled evaluation of patients with and without the use of ADMs in implant based breast reconstruction using the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) database. We aimed to assess baseline differences in demographics and co-morbidities between the two cohorts and to determine whether postoperative complication rates varied.
There was no internal or external financial support for this study. None of the authors have a financial interest in any of the products, devices, drugs or procedures mentioned in this manuscript.
Disclaimer:
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